Supernus updates Code of Ethics and Business Conduct on Dec 19, 2024

SUPERNUS PHARMACEUTICALS, INC.

Board of Directors approved an updated Code of Ethics and Business Conduct on December 19, 2024.
Updates clarify reporting channels, consequences for violations, conflicts of interest, and compliance guidance.
No waivers or implicit waivers were granted; code will be posted on the Investor Relations website.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SUPERNUS PHARMACEUTICALS, INC.: The Board approved and adopted an updated Code of Ethics and Business Conduct, clarifying reporting channels, consequences for violations, and guidance on conflicts of interest and legal compliance (effective 2024-12-19).

Change: code of ethics
Effective: 2024-12-19

Exact text from the filing

On December 19, 2024, the Board of Directors of the Company approved and adopted an updated Code of Ethics and Business Conduct (the “Code”).

View on SEC.gov

Browse all governance changes →

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-24-000069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.